X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001938678 Hughes Eric A TEVA PHARMACEUTICAL INDUSTRIES LTD. C/O 124 DVORA HANEVI'A ST. TEL AVIV L3 ISRAEL 0 1 0 0 See "Remarks" Restricted Share Units 2023-03-03 4 A 0 99601 0.00 A Ordinary Shares 99601 99601 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Executive Vice President, Global R&D and Chief Medical Officer /s/ Dov Bergwerk as attorney-in-fact for Eric A. Hughes 2023-03-07